January 19, 2017
A team of Dana-Farber scientists has released new research with an important message about precision medicine: Sequencing the genes of brain tumors in kids could point to treatments that target their genetic abnormalities and therefore have the best chance of being effective.
December 7, 2016
Colton was born healthy almost two years ago, but his fraternal twin brother, Levi, was not. The Michigan toddler had severe combined immune deficiency – “bubble boy” disease – discovered through newborn screening, Fox 17 reports from Grand Rapids.
November 4, 2016
Boston Children’s Hospital has established a new executive role to focus on research, the hospital announced.
Dr. David Williams, who serves as chief of hematology and oncology and director of clinical and translational research at Boston Children’s Hospital, will serve as chief scientific officer.
October 25, 2016
A Plus, a “positive journalism” site co-founded by Ashton Kutcher, highlights Dana-Farber/Boston Children’s oncologist Kira Bona’s research into the effects of poverty on childhood cancer outcomes, as well as resource specialist Joe Chabot’s work...
September 17, 2016
Leukemia is no longer the No. 1 cause of cancer deaths in children, but brain cancer has taken it's place, according to a new report.
September 16, 2016
The cancer moonshot’s dual focus for pediatrics should be improving outcomes in childhood cancers with low cure rates and alleviating the late effects of treatment, Dana-Farber/Boston Children’s President David A. Williams, MD, and other experts...